Fig. 1. Dramatic improvement of skin lesions after monthly injections of golimumab 50 mg, with improvement of the Psoriasis Area and Severity Index (PASI) score at 47 weeks of follow-up.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.